ENTITY

Biomarin Pharmaceutical (BMRN US)

58
Analysis
Health CareUnited States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
Refresh
Company Event02 Aug 2024 04:00 • Upcoming
Add To Calendar
Company Event25 Apr 2024 04:30 • Latest
Company Event23 Feb 2024 05:30
Company Event02 Nov 2023 04:30
Company Event13 Sep 2023 01:25
x